SCTB-41
- Generic Name
- SCTB-41
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 441
- Registration Number
- NCT06600022
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath